Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. (Q37089773)

18 August 2017

Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. (English)

1 reference

18 August 2017

0 references

1 reference

Mostafa M Elgebaly

1

1 reference

18 August 2017

Aisha Kelly

2

1 reference

18 August 2017

Alex K Harris

3

1 reference

18 August 2017

Hazem Elewa

4

1 reference

18 August 2017

Vera Portik-Dobos

5

1 reference

18 August 2017

Pimonrat Ketsawatsomkron

6

1 reference

18 August 2017

Mario Marrero

7

1 reference

18 August 2017

Adviye Ergul

8

1 reference

18 August 2017

1 June 2008

1 reference

Canadian Journal of Physiology and Pharmacology

18 August 2017

1 reference

18 August 2017

86

1 reference

18 August 2017

6

1 reference

18 August 2017

358-364

1 reference

Inflammation and metabolic disorders

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

From mice to men: insights into the insulin resistance syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Endothelins in chronic diabetic complications.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Insulin signalling and the regulation of glucose and lipid metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Plasma endothelin-1 levels in obese hypertensive and normotensive men.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Elevated plasma endothelin in patients with diabetes mellitus.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Increased plasma levels of endothelin in diabetic patients with hypertension

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Metabolic responses with endothelin antagonism in a model of insulin resistance

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Endothelin-mediated remodeling in aortas of diabetic rats

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Chronic endothelin-1 treatment leads to insulin resistance in vivo

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Endothelin A-receptor blockade in experimental diabetes improves glucose balance and gastrointestinal function

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3741337

Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1

3 September 2018

1 reference

12 December 2020

Endothelin limits insulin action in obese/insulin-resistant humans

1 reference

12 December 2020

Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease

1 reference

12 December 2020

Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes

1 reference

12 December 2020

Insulin signaling in health and disease

1 reference

12 December 2020

Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans

1 reference

12 December 2020

Identifiers

DOI

10.1139/Y08-034

1 reference

18 August 2017

1 reference

18 August 2017

1 reference